Martin Garrido-Rodriguez

Martin Garrido-Rodriguez

Auto-generated profile, based on publicly available information

Martin Garrido-Rodriguez

Molecular Systems Biology unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
DDDaniel Dimitrov
Daniel Dimitrov
DTDénes Türei
Dénes Türei
MGMartin Garrido-Rodriguez
Martin Garrido-Rodriguez
PBPaul L. Burmedi
Paul L. Burmedi
JNJames S. Nagai
James S. Nagai
JSJulio Saez-Rodriguez
Julio Saez-Rodriguez
The growing availability of single-cell data, especially transcriptomics, has sparked an increased interest in the inference of cell-cell communication. Many computational tools were developed for this purpose. Each of them consists of a resource of intercellular interactions prior knowledge and a method to predict potential cell-cell communication events. Yet the impact of the choice of resource and method on the resulting predictions is largely unknown. To shed light on this, we systematically compare 16 cell-cell communication inference resources and 7 methods, plus the consensus between the methods’ predictions. Among the resources, we find few unique interactions, a varying degree of overlap, and an uneven coverage of specific pathways and tissue-enriched proteins. We then examine all possible combinations of methods and resources and show that both strongly influence the predicted intercellular interactions. Finally, we assess the agreement of cell-cell communication methods with spatial colocalisation, cytokine activities, and receptor protein abundance and find that predictions are generally coherent with those data modalities. To facilitate the use of the methods and resources described in this work, we provide LIANA, a LIgand-receptor ANalysis frAmework as an open-source interface to all the resources and methods.

1 January 2020 in Redox Biology
Verified
Journal Article
Open access
LCLaura Casares
Laura Casares
VGVíctor García
Víctor García
MGMartín Garrido-Rodríguez
Martín Garrido-Rodríguez
EMEstrella Millán
Estrella Millán
JCJuan A. Collado
Juan A. Collado
EEduardo Muñoz
Eduardo Muñoz
Cannabidiol (CBD) is a major non-psychotropic phytocannabinoid that attracted a great attention for its therapeutic potential against different pathologies including skin diseases. However, although the efficacy in preclinical models and the clinical benefits of CBD in humans have been extensively demonstrated, the molecular mechanism(s) and targets responsible for these effects are as yet unknown. Herein we characterized at the molecular level the effects of CBD on primary human keratinocytes using a combination of RNA sequencing (RNA-Seq) and sequential window acquisition of all theoretical mass spectrometry (SWATH-MS). Functional analysis revealed that CBD regulated pathways involved in keratinocyte differentiation, skin development and epidermal cell differentiation among other processes. In addition, CBD induced the expression of several NRF2 target genes, with heme oxygenase 1 (HMOX1) being the gene and the protein most upregulated by CBD. CRISPR/Cas9-mediated genome editing, RNA interference and biochemical studies demonstrated that the induction of HMOX1 mediated by CBD, involved nuclear export and proteasomal degradation of the transcriptional repressor BACH1. Notably, we showed that the effect of BACH1 on HMOX1 expression in keratinocytes is independent of NRF2. In vivo studies showed that topical CBD increased the levels of HMOX1 and of the proliferation and wound-repair associated keratins 16 and 17 in the skin of mice. Altogether, our study identifies BACH1 as a molecular target for CBD in keratinocytes and sets the basis for the use of topical CBD for the treatment of different skin diseases including atopic dermatitis and keratin disorders.

25 October 2024 in Science
Verified
Journal Article
Closed access
LGLautaro Gandara
Lautaro Gandara
RJRichard Jacoby
Richard Jacoby
FLFrançois Laurent
François Laurent
MSMatteo Spatuzzi
Matteo Spatuzzi
NVNikolaos Vlachopoulos
Nikolaos Vlachopoulos
JCJustin Crocker
Justin Crocker
Insect biomass is declining globally, likely driven by climate change and pesticide use, yet systematic studies on the effects of various chemicals remain limited. In this work, we used a chemical library of 1024 molecules—covering insecticides, herbicides, fungicides, and plant growth inhibitors—to assess the impact of sublethal pesticide doses on insects. In Drosophila melanogaster , 57% of chemicals affected larval behavior, and a higher proportion compromised long-term survivability. Exposure to sublethal doses also induced widespread changes in the phosphoproteome and changes in development and reproduction. The negative effects of agrochemicals were amplified when the temperature was increased. We observed similar behavioral changes across multiple insect species, including mosquitoes and butterflies. These findings suggest that widespread sublethal pesticide exposure can alter insect behavior and physiology, threatening long-term population survival.

26 July 2022 in Molecular Systems Biology
Verified
Journal Article
Open access
MGMartin Garrido‐Rodriguez
Martin Garrido‐Rodriguez
KZKatharina Zirngibl
Katharina Zirngibl
OIOlga Ivanova
Olga Ivanova
SLSebastian Lobentanzer
Sebastian Lobentanzer
JSJulio Saez‐Rodriguez
Julio Saez‐Rodriguez
Signal transduction governs cellular behavior, and its dysregulation often leads to human disease. To understand this process, we can use network models based on prior knowledge, where nodes represent biomolecules, usually proteins, and edges indicate interactions between them. Several computational methods combine untargeted omics data with prior knowledge to estimate the state of signaling networks in specific biological scenarios. Here, we review, compare, and classify recent network approaches according to their characteristics in terms of input omics data, prior knowledge and underlying methodologies. We highlight existing challenges in the field, such as the general lack of ground truth and the limitations of prior knowledge. We also point out new omics developments that may have a profound impact, such as single‐cell proteomics or large‐scale profiling of protein conformational changes. We provide both an introduction for interested users seeking strategies to study cell signaling on a large scale and an update for seasoned modelers.

13 September 2018 in Molecular Oncology
Verified
Journal Article
Open access
PDF file
PMPaula Moreno
Paula Moreno
CJCarla Jiménez‐Jiménez
Carla Jiménez‐Jiménez
MGMartín Garrido‐Rodríguez
Martín Garrido‐Rodríguez
MCMónica Calderón‐Santiago
Mónica Calderón‐Santiago
SMSusana Molina
Susana Molina
MCMarco Antonio Calzado Canale
Marco Antonio Calzado Canale
Although metabolomics has attracted considerable attention in the field of lung cancer (LC) detection and management, only a very limited number of works have applied it to tissues. As such, the aim of this study was the thorough analysis of metabolic profiles of relevant LC tissues, including the most important histological subtypes (adenocarcinoma and squamous cell lung carcinoma). Mass spectrometry‐based metabolomics, along with genetic expression and histological analyses, were performed as part of this study, the widest to date, to identify metabolic alterations in tumors of the most relevant histological subtypes in lung. A total of 136 lung tissue samples were analyzed and 851 metabolites were identified through metabolomic analysis. Our data show the existence of a clear metabolic alteration not only between tumor vs. nonmalignant tissue in each patient, but also inherently intrinsic changes in both AC and SCC. Significant changes were observed in the most relevant biochemical pathways, and nucleotide metabolism showed an important number of metabolites with high predictive capability values. The present study provides a detailed analysis of the metabolomic changes taking place in relevant biochemical pathways of the most important histological subtypes of LC, which can be used as biomarkers and also to identify novel targets.

22 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
SMSophia Müller-Dott
Sophia Müller-Dott
EJEric J. Jaehnig
Eric J. Jaehnig
KMKhoi Pham Munchic
Khoi Pham Munchic
WJWen Jiang
Wen Jiang
TYTomer M. Yaron-Barir
Tomer M. Yaron-Barir
JSJulio Saez-Rodriguez
Julio Saez-Rodriguez
Kinases regulate cellular processes and are essential for understanding cellular function and disease. To investigate the regulatory state of a kinase, numerous methods have been developed to infer kinase activities from phosphoproteomics data using kinase-substrate libraries. However, few phosphorylation sites can be attributed to an upstream kinase in these libraries, limiting the scope of kinase activity inference. Moreover, inferred activities vary across methods, necessitating evaluation for accurate interpretation. Here, we present benchmarKIN, an R package enabling comprehensive evaluation of kinase activity inference methods. Alongside classical perturbation experiments, benchmarKIN introduces a tumor-based benchmarking approach utilizing multi-omics data to identify highly active or inactive kinases. We used benchmarKIN to evaluate kinase-substrate libraries, inference algorithms and the potential of adding predicted kinase-substrate interactions to overcome the coverage limitations. Our evaluation shows most computational methods perform similarly, but the choice of library impacts the inferred activities with a combination of manually curated libraries demonstrating superior performance in recapitulating kinase activities. Additionally, in the tumor-based evaluation, adding predicted targets from NetworKIN further boosts the performance. We then demonstrate how kinase activity inference aids characterize kinase inhibitor responses in cell lines. Overall, benchmarKIN helps researchers to select reliable methods for identifying deregulated kinases.